Global Cell and Gene Therapy Supply Chain and Logistics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at US$ 6740 million in 2025 and is forecast to a readjusted size of US$ 10816 million by 2032 with a CAGR of 6.7% during review period.
Cell and Gene Therapy Supply Chain and Logistics refers to a comprehensive, professional management and transportation system designed to ensure the safety, efficiency, and traceability of CGT drugs throughout the entire process from production to patients. Its core challenges lie in the highly personalized nature, extremely short shelf life, and stringent cryogenic requirements of CGT products. This system encompasses cold chain collection and transportation of biological samples, global sourcing of raw materials required for GMP production, cryogenic distribution of finished drugs, and a real-time temperature monitoring and traceability system throughout the entire process. Each step must strictly adhere to GMP standards to ensure cell viability and sterility; any temperature deviation or delay can lead to product failure. As the lifeline connecting laboratories, factories, and clinical settings, a high-quality supply chain and logistics are crucial for the commercial success of CGT drugs.
The global Cell and Gene Therapy Supply Chain and Logistics market is experiencing rapid growth driven by the accelerated commercialization of CGT drugs and the globalization of clinical trials. North America and Europe, as mature markets, leverage their leading cold chain technologies, comprehensive air networks, and stringent regulations to hold leading positions in cryogenic cold chain logistics, supply chain traceability systems, and global temperature-controlled container services. The Asia-Pacific region is the fastest-growing and most demand-driven sector. China and Southeast Asian countries, driven by a surge in cell therapy clinical research, the expansion of local production facilities, and cross-border medical needs, are rapidly developing cryogenic transportation networks, integrating with hospital supply chains, and establishing real-time monitoring platforms, leading to the rapid rise of local logistics service providers. The industry as a whole is accelerating its evolution towards end-to-end visualization, unmanned intelligent monitoring, and global supply chain integration.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Supply Chain and Logistics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Supply Chain and Logistics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care, Haemonetics, MasterControl, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin, and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2021 to 2026.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
Cell and Gene Therapy Supply Chain and Logistics refers to a comprehensive, professional management and transportation system designed to ensure the safety, efficiency, and traceability of CGT drugs throughout the entire process from production to patients. Its core challenges lie in the highly personalized nature, extremely short shelf life, and stringent cryogenic requirements of CGT products. This system encompasses cold chain collection and transportation of biological samples, global sourcing of raw materials required for GMP production, cryogenic distribution of finished drugs, and a real-time temperature monitoring and traceability system throughout the entire process. Each step must strictly adhere to GMP standards to ensure cell viability and sterility; any temperature deviation or delay can lead to product failure. As the lifeline connecting laboratories, factories, and clinical settings, a high-quality supply chain and logistics are crucial for the commercial success of CGT drugs.
The global Cell and Gene Therapy Supply Chain and Logistics market is experiencing rapid growth driven by the accelerated commercialization of CGT drugs and the globalization of clinical trials. North America and Europe, as mature markets, leverage their leading cold chain technologies, comprehensive air networks, and stringent regulations to hold leading positions in cryogenic cold chain logistics, supply chain traceability systems, and global temperature-controlled container services. The Asia-Pacific region is the fastest-growing and most demand-driven sector. China and Southeast Asian countries, driven by a surge in cell therapy clinical research, the expansion of local production facilities, and cross-border medical needs, are rapidly developing cryogenic transportation networks, integrating with hospital supply chains, and establishing real-time monitoring platforms, leading to the rapid rise of local logistics service providers. The industry as a whole is accelerating its evolution towards end-to-end visualization, unmanned intelligent monitoring, and global supply chain integration.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Supply Chain and Logistics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Cell and Gene Therapy Supply Chain and Logistics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Supply Chain and Logistics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care, Haemonetics, MasterControl, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Ordering and Scheduling Services
- Sample Collection Services
- Logistics Services
- Post Treatment Follow-Up Services
- Deep Cryogenic Cold Chain Logistics (-150? to -80?)
- Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
- Refrigerated Logistics (2? to 8?)
- Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
- Domestic/Regional Logistics
- Cross-Border Logistics
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Be The Match BioTherapies
- Biocair
- Marken
- World Courier
- MAK-SYSTEM
- Cryoport
- Brooks Life Sciences
- Hypertrust Patient Data Care
- Haemonetics
- MasterControl
- TraceLink
- TrakCel
- Stafa Cellular Therapy
- McKesson
- BioLife Solutions
- Patheon
- SF Express
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin, and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2021 to 2026.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2025
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Classification of Cell and Gene Therapy Supply Chain and Logistics by Temperature
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature: 2021 Versus 2025 Versus 2032
1.4.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Temperature in 2025
1.4.3 Deep Cryogenic Cold Chain Logistics (-150? to -80?)
1.4.4 Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
1.4.5 Refrigerated Logistics (2? to 8?)
1.4.6 Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
1.5 Classification of Cell and Gene Therapy Supply Chain and Logistics by Scope
1.5.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope: 2021 Versus 2025 Versus 2032
1.5.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Scope in 2025
1.5.3 Domestic/Regional Logistics
1.5.4 Cross-Border Logistics
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market by Application
1.6.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Biobank
1.6.3 Cell Therapy Lab
1.6.4 Hospital
1.6.5 Research Institute
1.7 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.8 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.8.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2021-2032)
1.8.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Hypertrust Patient Data Care
2.8.1 Hypertrust Patient Data Care Details
2.8.2 Hypertrust Patient Data Care Major Business
2.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.9 Haemonetics
2.9.1 Haemonetics Details
2.9.2 Haemonetics Major Business
2.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Haemonetics Recent Developments and Future Plans
2.10 MasterControl
2.10.1 MasterControl Details
2.10.2 MasterControl Major Business
2.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 MasterControl Recent Developments and Future Plans
2.11 TraceLink
2.11.1 TraceLink Details
2.11.2 TraceLink Major Business
2.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 TraceLink Recent Developments and Future Plans
2.12 TrakCel
2.12.1 TrakCel Details
2.12.2 TrakCel Major Business
2.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 TrakCel Recent Developments and Future Plans
2.13 Stafa Cellular Therapy
2.13.1 Stafa Cellular Therapy Details
2.13.2 Stafa Cellular Therapy Major Business
2.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.14 McKesson
2.14.1 McKesson Details
2.14.2 McKesson Major Business
2.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 McKesson Recent Developments and Future Plans
2.15 BioLife Solutions
2.15.1 BioLife Solutions Details
2.15.2 BioLife Solutions Major Business
2.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 BioLife Solutions Recent Developments and Future Plans
2.16 Patheon
2.16.1 Patheon Details
2.16.2 Patheon Major Business
2.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Patheon Recent Developments and Future Plans
2.17 SF Express
2.17.1 SF Express Details
2.17.2 SF Express Major Business
2.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 SF Express Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2026)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2032)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2032)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2025
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Classification of Cell and Gene Therapy Supply Chain and Logistics by Temperature
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature: 2021 Versus 2025 Versus 2032
1.4.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Temperature in 2025
1.4.3 Deep Cryogenic Cold Chain Logistics (-150? to -80?)
1.4.4 Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
1.4.5 Refrigerated Logistics (2? to 8?)
1.4.6 Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
1.5 Classification of Cell and Gene Therapy Supply Chain and Logistics by Scope
1.5.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope: 2021 Versus 2025 Versus 2032
1.5.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Scope in 2025
1.5.3 Domestic/Regional Logistics
1.5.4 Cross-Border Logistics
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market by Application
1.6.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Biobank
1.6.3 Cell Therapy Lab
1.6.4 Hospital
1.6.5 Research Institute
1.7 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.8 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.8.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2021-2032)
1.8.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Hypertrust Patient Data Care
2.8.1 Hypertrust Patient Data Care Details
2.8.2 Hypertrust Patient Data Care Major Business
2.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.9 Haemonetics
2.9.1 Haemonetics Details
2.9.2 Haemonetics Major Business
2.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Haemonetics Recent Developments and Future Plans
2.10 MasterControl
2.10.1 MasterControl Details
2.10.2 MasterControl Major Business
2.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 MasterControl Recent Developments and Future Plans
2.11 TraceLink
2.11.1 TraceLink Details
2.11.2 TraceLink Major Business
2.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 TraceLink Recent Developments and Future Plans
2.12 TrakCel
2.12.1 TrakCel Details
2.12.2 TrakCel Major Business
2.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 TrakCel Recent Developments and Future Plans
2.13 Stafa Cellular Therapy
2.13.1 Stafa Cellular Therapy Details
2.13.2 Stafa Cellular Therapy Major Business
2.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.14 McKesson
2.14.1 McKesson Details
2.14.2 McKesson Major Business
2.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 McKesson Recent Developments and Future Plans
2.15 BioLife Solutions
2.15.1 BioLife Solutions Details
2.15.2 BioLife Solutions Major Business
2.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 BioLife Solutions Recent Developments and Future Plans
2.16 Patheon
2.16.1 Patheon Details
2.16.2 Patheon Major Business
2.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Patheon Recent Developments and Future Plans
2.17 SF Express
2.17.1 SF Express Details
2.17.2 SF Express Major Business
2.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 SF Express Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2026)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2032)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2032)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2032)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Temperature, (USD Million), 2021 & 2025 & 2032
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Scope, (USD Million), 2021 & 2025 & 2032
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 8. Be The Match BioTherapies Major Business
Table 9. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 10. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Be The Match BioTherapies Recent Developments and Future Plans
Table 12. Biocair Company Information, Head Office, and Major Competitors
Table 13. Biocair Major Business
Table 14. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 15. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Biocair Recent Developments and Future Plans
Table 17. Marken Company Information, Head Office, and Major Competitors
Table 18. Marken Major Business
Table 19. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 20. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. World Courier Company Information, Head Office, and Major Competitors
Table 22. World Courier Major Business
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 24. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. World Courier Recent Developments and Future Plans
Table 26. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 27. MAK-SYSTEM Major Business
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 29. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MAK-SYSTEM Recent Developments and Future Plans
Table 31. Cryoport Company Information, Head Office, and Major Competitors
Table 32. Cryoport Major Business
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 34. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Cryoport Recent Developments and Future Plans
Table 36. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 37. Brooks Life Sciences Major Business
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 39. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Brooks Life Sciences Recent Developments and Future Plans
Table 41. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 42. Hypertrust Patient Data Care Major Business
Table 43. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 44. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 46. Haemonetics Company Information, Head Office, and Major Competitors
Table 47. Haemonetics Major Business
Table 48. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 49. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Haemonetics Recent Developments and Future Plans
Table 51. MasterControl Company Information, Head Office, and Major Competitors
Table 52. MasterControl Major Business
Table 53. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 54. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. MasterControl Recent Developments and Future Plans
Table 56. TraceLink Company Information, Head Office, and Major Competitors
Table 57. TraceLink Major Business
Table 58. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 59. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. TraceLink Recent Developments and Future Plans
Table 61. TrakCel Company Information, Head Office, and Major Competitors
Table 62. TrakCel Major Business
Table 63. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 64. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. TrakCel Recent Developments and Future Plans
Table 66. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 67. Stafa Cellular Therapy Major Business
Table 68. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 69. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Stafa Cellular Therapy Recent Developments and Future Plans
Table 71. McKesson Company Information, Head Office, and Major Competitors
Table 72. McKesson Major Business
Table 73. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 74. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. McKesson Recent Developments and Future Plans
Table 76. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 77. BioLife Solutions Major Business
Table 78. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 79. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. BioLife Solutions Recent Developments and Future Plans
Table 81. Patheon Company Information, Head Office, and Major Competitors
Table 82. Patheon Major Business
Table 83. Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 84. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Patheon Recent Developments and Future Plans
Table 86. SF Express Company Information, Head Office, and Major Competitors
Table 87. SF Express Major Business
Table 88. SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 89. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. SF Express Recent Developments and Future Plans
Table 91. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2021-2026)
Table 92. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2021-2026)
Table 93. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 94. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 95. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 96. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 97. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 98. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 99. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 100. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2021-2026)
Table 101. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2021-2026)
Table 102. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2027-2032)
Table 103. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026)
Table 104. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Application (2027-2032)
Table 105. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 106. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 107. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 108. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 109. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 116. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2027-2032) & (USD Million)
Table 123. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 124. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 125. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 126. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 127. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 130. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 131. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 132. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 133. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 136. Global Cell and Gene Therapy Supply Chain and Logistics Typical Customers
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Temperature, (USD Million), 2021 & 2025 & 2032
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Scope, (USD Million), 2021 & 2025 & 2032
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 8. Be The Match BioTherapies Major Business
Table 9. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 10. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Be The Match BioTherapies Recent Developments and Future Plans
Table 12. Biocair Company Information, Head Office, and Major Competitors
Table 13. Biocair Major Business
Table 14. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 15. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Biocair Recent Developments and Future Plans
Table 17. Marken Company Information, Head Office, and Major Competitors
Table 18. Marken Major Business
Table 19. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 20. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. World Courier Company Information, Head Office, and Major Competitors
Table 22. World Courier Major Business
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 24. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. World Courier Recent Developments and Future Plans
Table 26. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 27. MAK-SYSTEM Major Business
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 29. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MAK-SYSTEM Recent Developments and Future Plans
Table 31. Cryoport Company Information, Head Office, and Major Competitors
Table 32. Cryoport Major Business
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 34. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Cryoport Recent Developments and Future Plans
Table 36. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 37. Brooks Life Sciences Major Business
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 39. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Brooks Life Sciences Recent Developments and Future Plans
Table 41. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 42. Hypertrust Patient Data Care Major Business
Table 43. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 44. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 46. Haemonetics Company Information, Head Office, and Major Competitors
Table 47. Haemonetics Major Business
Table 48. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 49. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Haemonetics Recent Developments and Future Plans
Table 51. MasterControl Company Information, Head Office, and Major Competitors
Table 52. MasterControl Major Business
Table 53. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 54. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. MasterControl Recent Developments and Future Plans
Table 56. TraceLink Company Information, Head Office, and Major Competitors
Table 57. TraceLink Major Business
Table 58. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 59. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. TraceLink Recent Developments and Future Plans
Table 61. TrakCel Company Information, Head Office, and Major Competitors
Table 62. TrakCel Major Business
Table 63. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 64. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. TrakCel Recent Developments and Future Plans
Table 66. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 67. Stafa Cellular Therapy Major Business
Table 68. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 69. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Stafa Cellular Therapy Recent Developments and Future Plans
Table 71. McKesson Company Information, Head Office, and Major Competitors
Table 72. McKesson Major Business
Table 73. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 74. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. McKesson Recent Developments and Future Plans
Table 76. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 77. BioLife Solutions Major Business
Table 78. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 79. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. BioLife Solutions Recent Developments and Future Plans
Table 81. Patheon Company Information, Head Office, and Major Competitors
Table 82. Patheon Major Business
Table 83. Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 84. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Patheon Recent Developments and Future Plans
Table 86. SF Express Company Information, Head Office, and Major Competitors
Table 87. SF Express Major Business
Table 88. SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 89. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. SF Express Recent Developments and Future Plans
Table 91. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2021-2026)
Table 92. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2021-2026)
Table 93. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 94. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 95. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 96. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 97. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 98. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 99. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 100. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2021-2026)
Table 101. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2021-2026)
Table 102. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2027-2032)
Table 103. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026)
Table 104. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Application (2027-2032)
Table 105. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 106. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 107. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 108. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 109. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 116. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2027-2032) & (USD Million)
Table 123. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 124. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 125. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 126. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 127. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2021-2026) & (USD Million)
Table 130. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2027-2032) & (USD Million)
Table 131. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2021-2026) & (USD Million)
Table 132. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2027-2032) & (USD Million)
Table 133. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 136. Global Cell and Gene Therapy Supply Chain and Logistics Typical Customers
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2025
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Temperature in 2025
Figure 10. Deep Cryogenic Cold Chain Logistics (-150? to -80?)
Figure 11. Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
Figure 12. Refrigerated Logistics (2? to 8?)
Figure 13. Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Scope, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Scope in 2025
Figure 16. Domestic/Regional Logistics
Figure 17. Cross-Border Logistics
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application in 2025
Figure 20. Biobank Picture
Figure 21. Cell Therapy Lab Picture
Figure 22. Hospital Picture
Figure 23. Research Institute Picture
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2025
Figure 29. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2025
Figure 36. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue in 2025
Figure 38. Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
Figure 39. Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
Figure 40. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2021-2026)
Figure 41. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2027-2032)
Figure 42. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Application (2021-2026)
Figure 43. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Application (2027-2032)
Figure 44. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 54. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 61. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 64. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 78. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 79. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 80. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2025
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Temperature in 2025
Figure 10. Deep Cryogenic Cold Chain Logistics (-150? to -80?)
Figure 11. Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
Figure 12. Refrigerated Logistics (2? to 8?)
Figure 13. Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Scope, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Scope in 2025
Figure 16. Domestic/Regional Logistics
Figure 17. Cross-Border Logistics
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application in 2025
Figure 20. Biobank Picture
Figure 21. Cell Therapy Lab Picture
Figure 22. Hospital Picture
Figure 23. Research Institute Picture
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2025
Figure 29. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2025
Figure 36. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue in 2025
Figure 38. Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
Figure 39. Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2025
Figure 40. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2021-2026)
Figure 41. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2027-2032)
Figure 42. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Application (2021-2026)
Figure 43. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Application (2027-2032)
Figure 44. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 54. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 61. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 64. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 78. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 79. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 80. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
